zpět na hlavní stránku    kontakt
in english
English  
Česká společnost klinické farmakologie     Česká lékařská společnost J.E.P.


Prof. Philip Walson, MD, PhD
back to list

Philip Walson, MD is a US licensed physician who is Board Certified in Pediatrics, Clinical Pharmacology and Medical Toxicology. He is currently a Visiting Professor in the Department of Laboratory Medicine at Georg-August-University Medical School in Goettingen, Germany. He completed his undergraduate studies in Chemistry at the University of California, Berkeley and obtained his MD at the University of California, School of Medicine, San Francisco (UCSF). He trained in pediatrics in the Pritzker School of Medicine at the University of Chicago and afterwards returned to UCSF to complete a fellowship in clinical pharmacology at the Cardiovascular Research Institute in the UCSF Department of Internal Medicine.

His first academic position was in the Departments of Pediatrics and Pharmacology at the University of Arizona College of Medicine where he directed the Clinical Pharmacology fellowship training program and the Arizona Poison Control Center/System before moving to be Professor of Pediatrics, Pharmacology and Pharmacy at the Ohio State University/Childrens Hospital in Columbus as well as a member and chair of the Childrens IRB, Medical Director of the Central Ohio Poison Control Center, Director of the Therapeutic Drug Monitoring (TDM) and Toxicology Laboratory, and principal investigator of the National Institute of Child Health and Human Development (NICHD) supported Pediatric Pharmacology Research Unit (PPRU) and Pediatric Clinical Pharmacologist for the National Institute of Mental Health (NIMH) supported Research Unit for Pediatric Psychopharmacology (RUPP). He was also co-founder, Medical Director and Chief Scientific Officer of Pediatric Clinical Trials International, a for-profit subsidiary of the hospital dedicated to the development of pediatric therapeutics.

He then moved to Cincinnati Children's Hospital where he set up their Clinical Trials Office, was Director of the Clinical Pharmacology Division and the co-principal investigator for the University of Cincinnati PPRU, taught clinical study design, conducted clinical trials, and served on a number of academic and pharmaceutical company sponsored DSMB's/DMC's. He then moved to Europe to work part-time as a university researcher/teacher as well as a consultant to industry, CRO's, and government (US and EU) as well as serving on numerous academic and pharmaceutical company DSMB's/DMC's including the DMC he chairs that monitors NICHD/FDA sponsored studies of off-patent drugs studied as part of the Best Pharmaceuticals for Children Act (BPCA).
 
© 2018 ČSKF     Valid HTML 4.01 Transitional